—

Lantheus Holdings Inc (LNTH) — the peer cohort

As of 2026-10-08 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Lantheus Holdings Inc ranks 6 of 11 in its cohort on the Closelooknet composite (60/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
LNTH Lantheus Holdings Inc 60 68 74 57 info 10.5%
ROVI.MC Laboratorios Farmaceuticos ROVI 61 27 77 52 warn 31.8%
KNSA Kiniksa Pharmaceuticals Ltd 57 94 59 21 ok 5.1%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 54 89 58 42 ok 7.2%
GALDY GALDERMA GROUP AG 54 44 59 28 info 15%
ALM.MC Almirall S.A. 53 22 46 68 warn 27.1%
FAGR.BR Fagron NV 52 43 56 60 info 11.9%
HALO Halozyme Therapeutics Inc 74 94 94 51 ok 6%
DXCM DexCom Inc 66 83 80 37 watch 9%
ONC BeiGene, Ltd. 64 77 64 32 info 9.1%
MEDP Medpace Holdings Inc 63 82 75 30 ok 11.1%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-08

Quick answers

Who are Lantheus Holdings Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Kiniksa Pharmaceuticals Ltd (KNSA), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), GALDERMA GROUP AG (GALDY), Almirall S.A. (ALM.MC), Fagron NV (FAGR.BR), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM) and others.

How does LNTH score against its peers?

Lantheus Holdings Inc's composite reads 60/100, ranking 6 of 11 in its cohort as of 2026-10-08; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.